Kevin D. Brandt - Aug 15, 2023 Form 4 Insider Report for Xtant Medical Holdings, Inc. (XTNT)

Role
Chief Commercial Officer
Signature
/s/ Amy E. Culbert, attorney-in-fact
Stock symbol
XTNT
Transactions as of
Aug 15, 2023
Transactions value $
-$58,858
Form type
4
Date filed
8/17/2023, 04:46 PM
Previous filing
Aug 17, 2022
Next filing
Nov 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XTNT Common Stock Award $0 +120K +17.13% $0.00 824K Aug 15, 2023 Direct F1, F2
transaction XTNT Common Stock Tax liability -$58.9K -49.9K -6.05% $1.18 774K Aug 15, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XTNT Stock Option (right to buy) Award $0 +141K $0.00 141K Aug 15, 2023 Common Stock 141K $1.20 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares will vest and be issued with respect to 30,125 shares on each of August 15, 2024, August 15, 2025 and August 15, 2026 and with respect to 30,124 shares on August 15, 2027 pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining an employee of Xtant through the vesting date.
F2 Includes 120,499 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan and 412,411 shares to be issued upon vesting pursuant to restricted stock unit awards granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, as amended, all conditioned upon the Reporting Person remaining an employee of Xtant through the vesting dates.
F3 This option vests with respect to 35,146 shares on August 15, 2024 and with respect to the remaining 75% of such shares over the three-year period thereafter in 12 as nearly equal as possible quarterly installments, conditioned upon the Reporting Person remaining an employee of Xtant through the vesting date.